M. A. Phillips‡, Lotharius, J., Marsh, K., White, J., Dayan, A., White, K. L., Njoroge, J. W., Mazouni, F. El, Lao, Y., Kokkonda, S., Tomchick, D. R., Deng, X., Laird, T., Bhatia, S. N., March, S., Ng, C. L., Fidock, D. A., Wittlin, S., Lafuente-Monasterio, M., Benito, F. Javier Gam, Alonso, L. Maria Sanz, Martinez, M. Santos, Jimenez-Diaz, M. Belen, Bazaga, S. Ferrer, Angulo-Barturen, I., Haselden, J. N., Louttit, J., Cui, Y., Sridhar, A., Zeeman, A. - M., Kocken, C., Sauerwein, R., Dechering, K., Avery, V. M., Duffy, S., Delves, M., Sinden, R., Ruecker, A., Wickham, K. S., Rochford, R., Gahagen, J., Iyer, L., Riccio, E., Mirsalis, J., Bathhurst, I., Rueckle, T., Ding, X., Campo, B., Leroy, D., M. Rogers, J., Rathod, P. K., Burrows, J. N., and Charman, S. A. ‡,
“A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria”,
Science Translational Medicine, vol. 7, pp. 296ra111–296ra111, 2015.
